Showing results (1751-1760 of 2,791) with videos related to

Sort By:
Pageof 280
Cytotherapy|June 29, 2021
Development of T-cell immunity in a liver and hematopoietic stem cell transplant recipient following coronavirus disease 2019 infectionMithil Soni, Edoardo Migliori, Amer Assal, et al.
Cytotherapy|May 25, 2022
Proceedings of the ISCT scientific signature series symposium, "Advances in cell and gene therapies for lung diseases and critical illnesses": International Society for Cell & Gene Therapy, Burlington VT, US, July 16, 2021Anthony E Ting, Elizabeth K Baker, Josee Champagne, et al.
Cytotherapy|June 1, 2022
Impact considerations of post-production processes on cell and gene drug productsJohn Fink, Michael Scott, Sebastian Rieck, et al.
Cytotherapy|January 21, 2018
Handling, processing and disposal of stem cell products in Europe: A survey by the cellular therapy and immunobiology working party of the European Society for Blood and Marrow TransplantationAndreas Holbro, Helen Baldomero, Francesco Lanza, et al.
Cytotherapy|February 4, 2018
Variation in primary and culture-expanded cells derived from connective tissue progenitors in human bone marrow space, bone trabecular surface and adipose tissueMaha A Qadan, Nicolas S Piuzzi, Cynthia Boehm, et al.
Cytotherapy|February 5, 2018
Human endometrial stem cells: High-yield isolation and characterizationMarina V Kovina, Michael E Krasheninnikov, Tatiana G Dyuzheva, et al.
Cytotherapy|February 6, 2018
Proceedings of the signature series event of the international society for cellular therapy: "Advancements in cellular therapies and regenerative medicine in digestive diseases," London, United Kingdom, May 3, 2017Rachele Ciccocioppo, Claudia C Dos Santos, Daniel C Baumgart, et al.
Cytotherapy|January 8, 2018
Platelet-rich plasma-derived scaffolds increase the benefit of delayed mesenchymal stromal cell therapy after severe traumatic brain injuryCelia Bonilla Horcajo, Mercedes Zurita Castillo, Jesús Vaquero Crespo
Cytotherapy|December 12, 2018
Mesenchymal stromal cell therapy: progress in manufacturing and assessments of potencyKevin P Robb, Joan C Fitzgerald, Frank Barry, et al.
Cytotherapy|March 18, 2018
Inducible indoleamine 2,3-dioxygenase 1 and programmed death ligand 1 expression as the potency marker for mesenchymal stromal cellsQingdong Guan, Yun Li, Tanner Shpiruk, et al.
Pageof 280